30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Neuphoria Therapeutics Inc (NEUP)

Track

The most recent insider trading activity at Neuphoria Therapeutics Inc. occurred on October 21, 2025, with a significant buy transaction of 639,110 shares valued at $3,283,108.07 by Lynx1 Capital Management LP. This represents the sole reported transaction within the analyzed period, indicating a notable acquisition by a major stakeholder.
Stock chart
Ticker: NEUP Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Lynx1 Capital Management LP
1 purchase — total 3,283,108 USD
Buy 21 Oct 2025
Value US$4,553,047.76 | Price 56.82 | Shares 38,252
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-23 2025-10-21 B Purchase
4.1
Lynx1 Capital Management LP
Large shareholder
38,252 +20.6%
56.82
US$4,553,048 		38,252 +20.6% 56.82 US$4,553,048
Explore more

More insider trading research around Neuphoria Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America